17.12.2025
After the november holidays, demand for antiviral medicines resumed growth in Russia, with a clear upward trend observed from 5 November 2025
In 2025, physical sales volumes of antiviral medicines used for the treatment of influenza and other acute respiratory viral infections have remained largely stagnant. Between 1 January and 23 November 2025, a total of 70.5 million packs of such medicines were sold in Russia, which is 0.7% less than in the same period of 2024.
16.12.2025
Consumption of anti-ulcer medicines is increasing in 82 Russian regions, with retail demand growing for the third consecutive year
On the Russian retail pharmaceutical market, a total of 115.6 million packs of anti-ulcer medicines (EphMRA group A02B) were sold in January–October 2025, amounting to RUB 25.0 billion at retail prices, including VAT.
15.12.2025
Consolidation processes in the Russian pharmaceutical wholesale segment in 2025 are largely driven by the top five players
The combined market share of the largest Russian pharmaceutical distributors within the TOP-25 in the direct deliveries segment amounted to 77% as of the first three quarters of 2025. Over the year, the level of concentration in the wholesale segment increased only marginally — by just 0.55%.
11.12.2025
Demand for medical oxygen concentrators in Russia has intensified, with growth exceeding 40% for the second consecutive year
In the first ten months of 2025, 40.8 thousand medical oxygen concentrators were sold in the Russian retail market, including marketplace and FMCG channels, with total sales amounting to 867.0 million rubles.
10.12.2025
Generic rivaroxaban products have stimulated strong volume growth in antithrombotic sales in the Russian retail market
The total retail sales volume of antithrombotic agents (EphMRA group B01) reached 49.3 billion rubles in January–October 2025, with more than 58.3 million packs sold during the period.
09.12.2025
Growth rates of the online channel in Russian pharmacy retail are slowing, yet still triple the overall market dynamics
The total volume of online sales and reservations of pharmacy assortment products (medicines and parapharmaceuticals) reached 408.7 billion rubles in Q1–Q3 2025.
08.12.2025
Infrastructure of the Russian pharmacy retail sector enters a phase of quantitative decline in 2025 as the number of pharmacies begins to shrink
Ranking of Pharmacy Chains and Associations by Share of the Commercial Retail Market for Medicines in Russia, January–September 2025
04.12.2025
Rostov Oblast and Stavropol Krai are the absolute leaders in per capita consumption of gabapentin products
At the end of November, the Russian Ministry of Health published an Order expanding the list of medicines subject to itemised quantitative control. Among the four newly added positions was gabapentin, an anti-epileptic drug; however, the restrictions will only take effect on 1 March 2026.
03.12.2025
Every second nebulizer in Russia is purchased via marketplaces, the share of the online channel in 2025 has increased to 51.5%
The Russian retail market for nebulizers totalled 3.59 billion RUB in the first ten months of 2025. Compared with the same period of the previous year, the sales value of these devices declined by 10.9%.
02.12.2025
Russians have spent almost 54 billion rubles on nasal preparations since the beginning of 2025
As of January–October 2025, the retail market for locally acting nasal disease treatments reached 53.8 billion rubles. Total consumer spending within the category increased by 8.3 percent compared to the same period in 2024.
Read more
1
4
